Top holdings include: Pharmasset (NasdaqGS: VRUS) 1.47%, Perrigo Co. (NasadaqGS: PRGO) 1.22%, Hansen Natural Co. (NasdaqGS: HANS) 1.15%, Avago Technologies (NasdaqGS: AVGO) 1.06% and Nuance Communications (NasdaqGS: NUAN) 1.03%.
According to a press release, companies in both the indices have shown strong earnings growth and have shown profitability over the past five or more years. From January 1 to September 30, 2011, both the NASDAQ 500 and 400 Indices have outperformed the S&P 500 and 400 by more than 3%.
“We are pleased to be pairing with NASDAQ OMX, a recognized leader in the development of innovative indices, to bring these products to market,” Bruno del Ama, CEO of Global X Funds, said in the press release. “Both new funds expand the coverage beyond the NASDAQ 100 Index, providing greater diversification and possibly capturing the next Apple or Google.”
“NASDAQ OMX and Global X Funds share a common goal to provide investors with the chance to access some of the world’s most innovative companies and these new indexes and ETFs are the latest examples of that commitment,” John Jacobs, Executive V.P. at the NASDAQ OMX Global Index Group, said.
For more information on new funds, visit our new ETFs category.
Max Chen contributed to this article.